Cargando…

Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer

Detalles Bibliográficos
Autores principales:	Li, Wanshuai, Wang, Yong, Zhang, Qi, Tang, Lili, Liu, Xiaoping, Dai, Yunhua, Xiao, Liang, Huang, Shuguang, Chen, Lu, Guo, Zhongmin, Yuan, Kai, Lu, Jim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732608/ https://www.ncbi.nlm.nih.gov/pubmed/26824229 http://dx.doi.org/10.1371/journal.pone.0148589

Ejemplares similares

MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
por: Li, Wanshuai, et al.
Publicado: (2015)

MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification
por: Fernández-Villabrille, Sara, et al.
Publicado: (2023)

Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults
por: Liu, Huang-Chun, et al.
Publicado: (2021)

MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions
por: ElKhouly, Aisha M., et al.
Publicado: (2020)

Correction: Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer
por: Hennessey, Patrick T., et al.
Publicado: (2012)

The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis
por: Ji, Xiaoming, et al.
Publicado: (2015)

MicroRNA 486-3P as a stability marker in acute coronary syndrome
por: Wei, Tianling, et al.
Publicado: (2016)

miR-486 as an unfavorable prognostic biomarker for patients with non-small cell lung cancer
por: Gao, Zhao-Jia, et al.
Publicado: (2020)

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
Publicado: (2016)

Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637
por: Zheng, Xiaotao, et al.
Publicado: (2021)

Salivary Exosomal MicroRNA-486-5p and MicroRNA-10b-5p in Oral and Oropharyngeal Squamous Cell Carcinoma
por: Faur, Cosmin Ioan, et al.
Publicado: (2022)

Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men
por: Aoi, Wataru, et al.
Publicado: (2013)

Overexpression of microRNA-486 affects the proliferation and chemosensitivity of mesothelioma cell lines by targeting PIM1
por: Pinelli, Silvana, et al.
Publicado: (2021)

Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer
por: Papadaki, Chara, et al.
Publicado: (2022)

Serum microRNAs as biomarkers for recurrence in melanoma
por: Friedman, Erica B, et al.
Publicado: (2012)

Correction: Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs
por: Shivapurkar, Narayan, et al.
Publicado: (2014)

Correction: A urinary extracellular vesicle microRNA biomarker discovery pipeline; from automated extracellular vesicle enrichment by acoustic trapping to microRNA sequencing
por: Ku, Anson, et al.
Publicado: (2019)

Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression
por: Yang, N., et al.
Publicado: (2017)

MicroRNA 486-3p directly targets BIK and regulates apoptosis and invasion in colorectal cancer cells
por: Feng, Li, et al.
Publicado: (2018)

MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1
por: Chou, Sung-Tau, et al.
Publicado: (2019)

Correction: Genetic Variants in MicroRNA Machinery Genes Are Associate with Idiopathic Recurrent Pregnancy Loss Risk
Publicado: (2014)

Skeletal muscle-specific overexpression of miR-486 limits mammary tumor-induced skeletal muscle functional limitations
por: Wang, Ruizhong, et al.
Publicado: (2022)

Identification of microRNA-451a as a Novel Circulating Biomarker for Colorectal Cancer Diagnosis
por: Zhang, Zhen, et al.
Publicado: (2020)

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
por: Zhang, Zhu-qing, et al.
Publicado: (2014)

MicroRNA-486-5p inhibits the growth of human hypertrophic scar fibroblasts by regulating Smad2 expression
por: Shi, Yingying, et al.
Publicado: (2019)

MicroRNA-486-5p Suppresses Lung Cancer via Downregulating mTOR Signaling In Vitro and In Vivo
por: Ding, Lei, et al.
Publicado: (2021)

MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis
por: Jiang, Min, et al.
Publicado: (2018)

MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
por: Liao, Jipei, et al.
Publicado: (2020)

Identification of microRNAs in Throat Swab as the Biomarkers for Diagnosis of Influenza
por: Peng, Fang, et al.
Publicado: (2016)

Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer
por: Du, Lutao, et al.
Publicado: (2017)

Correction: Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus
por: Salama, Iman I., et al.
Publicado: (2020)

Correction: Human MicroRNA Targets
por: John, Bino, et al.
Publicado: (2005)

Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486
por: Xu, Jing, et al.
Publicado: (2012)

Long Non-Coding RNA LINC02802 Regulates In Vitro Sprouting Angiogenesis by Sponging microRNA-486-5p
por: Rosano, Stefania, et al.
Publicado: (2022)

Circ‐TCF4.85 silencing inhibits cancer progression through microRNA‐486‐5p‐targeted inhibition of ABCF2 in hepatocellular carcinoma
por: Gao, Jun, et al.
Publicado: (2020)

Correction: Regulation of MicroRNA-155 in Atherosclerotic Inflammatory Responses by Targeting MAP3K10
por: Zhu, Jianhua, et al.
Publicado: (2013)

Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma
por: Zhang, Yanqing, et al.
Publicado: (2017)

Correction: Cross validated serum small extracellular vesicle microRNAs for the detection of oropharyngeal squamous cell carcinoma
por: Mayne, G. C., et al.
Publicado: (2022)

Correction: Urinary MicroRNA Profiling in the Nephropathy of Type 1 Diabetes
por: Argyropoulos, Christos, et al.
Publicado: (2013)

MicroRNAs as Biomarkers for the Diagnosis of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
por: Li, Jiangbi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_du4o52hnlouvmpgob265m18e1p